Year: 2000 Source: Clinical Neuropharmacology, v.23, no.6, (November-December 2000), p.335-337 SIEC No: 20020562

Risperidone has been primarily marketed for the treatment of schizophrenia. There are reports about its potential role for the treatment of affective illness. We report here another case of a patient with psychotic depression who was treated successfully with risperidone as monotherapy. This case report suggests that risperidone can be an efficient treatment mode for psychotic depression; however, it needs more data based on controlled study. (28 refs)